Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 618-624

  Clausing, Peter ^a,b   Newport, Glenn D ^a   Bowyer, John F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b LAB Research Denmark   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; FENFLURAMINE; NORFENFLURAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DETERMINATION; FRONTAL CORTEX; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BODY TEMPERATURE; BRAIN; CEREBRAL CORTEX; DIALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FENFLURAMINE; HYDROXYINDOLEACETIC ACID; MALE; NORFENFLURAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0031886643     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Allen DD, Orvig C and Yokel RA (1994) Pharmacokinetics and distribution of tris(maltolato)aluminium(III) into the central nervous system. Neurotoxicology 15:371-378.
2. Alonso MJ, Bruelisauer A, Misslin P and Lemaire M (1995) Microdialysis sampling to determine the pharmacokinetics of unbound SDZ ICM 567 in blood and brain in awake, freely-moving rats. Pharmacol Res 12:291-294.
3. Anelli M, Fracasso C, Bergami A, Ferrarese A, Garattini S and Caccia S (1995) Effect of d-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymes. Psychopharmacology 118:188-194.
4. Appel NM, Mitchell WMM, Contrera JF and De Souza EB (1990) Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse 6:33-44.
5. Baumgarten G, Garattini S, Lorens S and Wurtman R (1992) Dexfenfluramme and neurotoxicity. Lancet 339:359.
6. Blundell JE, Campbell DB, Lesham M and Tozer R (1975) Comparison of the time course of the anorectic effect of fenfluramine and amphetamine with drug levels in blood. J Pharm Pharmacol 27:187-192.
7. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr and Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571-1580.
8. Bowyer JF and Holson RR (1995) Methamphetamine and amphetamine neurotoxicity, in Handbook of Neurotoxicology (Chang LW and Dyer RS eds) pp 845-870, Marcel Dekker, New York.
9. Bradberry CW, Nobiletti JB, Elsworth JD, Murphy B, Jatlow P and Roth RH (1993) Cocaine and cocaethylene: Microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem 60:1429-1435.
10. Caccia S, Anelli M, Ferrarese A, Fracasso C and Garattini S (1992) Single- and multiple-dose kinetics of d-fenfluramine in rats given anorectic and toxic doses. Xenobiotica 22:217-226.
11. Clausing P, Gough B, Holson RR, Slikker W Jr and Bowyer JF (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 274:614-621.
12. Clausing P, Bloom D, Newport GD, Holson RR, Slikker W Jr and Bowyer JF (1996) Individual differences in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putamen. Psychopharmacology 127:187-194.
13. Clausing P, Rushing L, Newport GD and Bowyer JF (1997) Determination of dfenfluramine, d-norfenfluramine and fluoxetine in plasma, brain tissue and brain microdialysate using high-performance liquid chromatography after precolumn derivatization with dansyl-chloride. J Chromatgr B 692:419-426.
14. Clineschmidt BV, Totaro JA, Mcguffin JC and Pflueger AB (1976) Fenfluramine: long-term reduction in brain serotonin (5-hydroxytryptamine). Eur J Pharmacol 35:211-214.
15. Clineschmidt BV, Zacchei AG, Totaro JA, Pflueger AB, Mcguffin JC and Wishousky TI (1978) Fenfluramine and brain serotonin. Ann NY Acad Sci 308:222-241.
16. Fuller RW, Snoddy HD and Robertson DW (1988) Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: Uptake inhibition versus release. Pharmacol Biochem Behav 30:715-721.
17. Garattini S (1985) Active drug metabolites. An overview of their relevance in clinical pharmacokinetics. Clin Pharmacokinet 10:216-227.
18. Gobbi M, Mancini L, Presti ML and Mennini T (1996) Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of d-fenfluramine. Brain Res 730:165-172.
19. 3H]serotonin. Naunyn-Schmiedeberg's Arch Pharmacol 354:1-6.
20. Harvey JA and McMaster SE (1975) Fenfluramine: evidence for neurotoxic action on midbrain and long-term depletion of serotonin. Psychopharmacol Commun 1:217-228.
21. Hirano H, Day J and Fibiger HC (1995) Serotonergic regulation of acetylcholine release in rat frontal cortex. J Neurochem 65:1139-1145.
22. Hooks MS, Jones GH, Liem BJ and Justice JB Jr (1992) Sensitization and individual differences to ip amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions. Pharmacol Biochem Behav 43:815-823.
23. Jori A, De Ponte P and Caccia S (1978) Stereoselective disposition of fenfluramine enantiomers in the rat. Xenobiotica 8:583-588.
24. Kleven MS, Schuster CR and Seiden LS (1988) Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. J Pharmacol Exp Ther 246:822-828.
25. Kieven MS and Seiden LS (1989) d-, l-, and d, l-fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Res 505:351-353.
26. 3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Dev Brain Res 78:142-146.
27. Kreiss DS, Wieland S and Lucki I (1993) The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience 52:295-301.
28. Lorens SA, Hata N and Cabrera T (1990) Comparison of the behavioural and neurochemical effects of 5,7-DHT, MDMA, and d,l-fenfluramine. NIDA Res Monogr Ser 95:347.
29. McTavish D and Heel RC (1992) Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. Drugs 43:713-733.
30. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, New York.
31. Rowland NE and Carlton J ( 1986) Neurobiology of an anorectic drug: Fenfluramine. Prog Neurobiol 27:13-62.
32. Schwartz D, Hernandez L and Hoebel BG (1989) Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res 482:261-270.
33. Segal DS and Kuczenski R (1994) Behavioral pharmacology of amphetamine, in Amphetamine and Its Analogues. Psychopharmacology, Toxicology, and Abuse (Cho AK and Segal DS eds) pp 115-150, Academic Press, San Diego.
34. Seiden LS and Sabol KE (1995) Neurotoxicity of methamphetamine-related drugs and cocaine, in Handbook of Neurotoxicology (Chang LW and Dyer RS eds) vol 2, pp. 824-844, Marcel Dekker, Inc., New York.
35. Series HG, Cowen PJ and Sharp T (1994) p-Chloroamphetamine (PCA), 3,4-meth-ylenedioxymethamphetamine (MDMA) and d-fenfluramine pretreatment attenu-ates d-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology 116:508-514.
36. Slikker W Jr, Ali SF, Scallet AC, Frith CH, Newport GD and Bailey JR (1988) Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA). Toxicol Appl Pharmacol 94:448-457.
37. Ståhle L (1991) Drug distribution studies with microdialysis: I. Tissue dependent difference in recovery between caffeine and theophylline. Life Sci 49:1835-1842.
38. Steranka LR and Sanders-Bush E (1979) Long-term effects of fenfluramine on central serotonergic mechanisms. Neuropharmacology 18:895-903.
39. Stewart CW, Bowyer JF and Slikker W Jr (1997) Elevated environmental temperature can induce hyperthermia during d-fenfluramine exposure and enhance 5-HT depletion in the brain. J Pharmacol Exp Ther 283:1144-1150.
40. Tallarida RJ and Murray RB (1986) Manual of Pharmacologic Calculations with Computer Programs, 2nd ed. Springer, New York.
41. Ungerstedt U (1984) Measurement of neurotransmitter release by intracranial dialysis, in Measurement of Neurotransmitter Release in Vivo (Marsden CA ed) pp 81-105, John Wiley & Son Ltd., New York.
42. Viana MB, Silveira R and Graeff FG ( 1996) D-fenfluramine selectively releases 5-HT from dorsal raphe terminals. Braz J Med Biol Res 29:639-642.
43. Westphalen RI and Dodd PR (1995) The nature of d,l-fenfluramine-induced 5-HT reuptake transporter loss in rats. Mol Neurobiol 11:165-175.
44. Wong DT, Bymaster FP, Horng JS and Molloy BB (1975) A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. J Pharmacol Exp Ther 193:804-811.